Section Arrow
SEPN.NASDAQ
- Septerna Inc
Quotes are at least 15-min delayed:2026/06/06 01:59 EDT
Regular Hours
Last
 31.15
-0.22 (-0.70%)
Day High 
31.41 
Prev. Close
31.37 
1-M High
31.79 
Volume 
211.65K 
Bid
23.05
Ask
49.1
Day Low
30.47 
Open
30.99 
1-M Low
23.29 
Market Cap 
1.41B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 29.98 
20-SMA 27.85 
50-SMA 25.9 
52-W High 32.63 
52-W Low 9.8515 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.80/-3.21
Enterprise Value
1.44B
Balance Sheet
Book Value Per Share
8.40
Cash Flow
Cash Flow Yield
0.08
Income Statement
Total Revenue
45.95M
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BCDABioCardia Inc.1.03+0.111+12.08%-- 
BGMSBio Green Med Solution Inc1.5+0.44+41.51%0.3PE
CMNDClearmind Medicine Inc.3.98+1.07+36.77%-- 
ADTXAditxt Inc.0.0621-0.0149-19.35%-- 
RXRXRecursion Pharmaceuticals3.315-0.485-12.76%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.